|

CD4CAR Clinical Trials

3 actively recruiting trials across 1 location

Pipeline

Phase 1: 3

Top Sponsors

  • Huda Salman3

Indications

  • Cancer3
  • T-cell Leukemia1
  • T - Cell Lymphoma1
  • Chronic Myelomonocytic Leukemia1
  • Acute Myeloid Leukemia1

Miami, Florida3 trials

CD4CAR for CD4+ Leukemia and Lymphoma

University of Miami Sylvester Comprehensive Cancer Center

Phase 1
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant

University of Miami Sylvester Comprehensive Cancer Center

Phase 1
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida 33136

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.